International Assets Investment Management LLC Makes New Investment in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

International Assets Investment Management LLC bought a new stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) during the fourth quarter, HoldingsChannel.com reports. The fund bought 8,669 shares of the company’s stock, valued at approximately $100,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Raymond James Financial Services Advisors Inc. raised its position in Global X Genomics & Biotechnology ETF by 9.0% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 250,986 shares of the company’s stock valued at $2,901,000 after purchasing an additional 20,812 shares during the period. Archford Capital Strategies LLC grew its stake in shares of Global X Genomics & Biotechnology ETF by 15.6% in the fourth quarter. Archford Capital Strategies LLC now owns 23,076 shares of the company’s stock valued at $267,000 after buying an additional 3,107 shares in the last quarter. Lido Advisors LLC raised its holdings in shares of Global X Genomics & Biotechnology ETF by 7.8% during the 3rd quarter. Lido Advisors LLC now owns 355,245 shares of the company’s stock valued at $3,613,000 after buying an additional 25,791 shares during the period. One Capital Management LLC lifted its position in Global X Genomics & Biotechnology ETF by 4.6% during the 3rd quarter. One Capital Management LLC now owns 540,278 shares of the company’s stock worth $5,495,000 after acquiring an additional 23,889 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its holdings in Global X Genomics & Biotechnology ETF by 11.5% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 54,114 shares of the company’s stock worth $550,000 after acquiring an additional 5,598 shares during the period. Institutional investors and hedge funds own 56.95% of the company’s stock.

Global X Genomics & Biotechnology ETF Stock Up 2.0 %

Shares of NASDAQ:GNOM opened at $10.00 on Tuesday. The company has a 50 day moving average of $11.11 and a two-hundred day moving average of $10.80. Global X Genomics & Biotechnology ETF has a 52-week low of $8.63 and a 52-week high of $13.33. The company has a market capitalization of $91.20 million, a price-to-earnings ratio of -4.27 and a beta of 1.03.

About Global X Genomics & Biotechnology ETF

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.